Why the study?
The clinical importance of coronary slow flow remains debatable, prompting investigation into its predictors and clinical outcomes in diabetic patients with chronic coronary syndrome.
Does the presence of coronary slow flow phenomenon increase the risk of major adverse cardiac events in diabetic patients with chronic coronary syndrome?
Does the presence of coronary slow flow phenomenon increase the risk of major adverse cardiac events in diabetic patients with chronic coronary syndrome?
CSF identification does not significantly predict higher MACE in diabetic CCS; leaves open its prognostic value for future studies.
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: